Hyundai Bioscience announced that Xafty™, a broad-spectrum antiviral drug, can solve RNA virus infections, capable of treating both COVID-19 and Dengue fever or Dengue virus infection". It was announced on October 13, 2023, at IDWeek 2023, a prestigious conference in the field of infectious diseases held in Boston.